← Browse by Condition
Medical Condition

gastro esophageal junction adenocarcinoma

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 2
NCT06808971 Phase 2
Recruiting

Adebrelimab Combined With Nab-paclitaxel, Oxaliplatin and Tegafur (AOS) for Perioperative Treatment of Locally Advanced Resectable GC/GEJ

Enrollment
61 pts
Location
China
Sponsor
Cancer Institute and Hospital,...
View Trial →